Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan

Yerbol Burashev; Bekbolat Usserbayev; Lespek Kutumbetov; Yergali Abduraimov; Markhabat Kassenov; Aslan Kerimbayev; Balzhan Myrzakhmetova; Aibarys Melisbek; Meirzhan Shirinbekov; Saken Khaidarov; Edan R Tulman

doi:10.1128/mra.01114-22

Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan

Microbiol Resour Announc. 2022 Dec 15;11(12):e0111422. doi: 10.1128/mra.01114-22. Epub 2022 Nov 14.

Affiliations

¹ Research Institute for Biological Safety Problems (RIBSP), Gvardeyskiy, Kazakhstan.
² Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
³ Department of Pathobiology and Veterinary Science and Center of Excellence for Vaccine Research, University of Connecticut, Storrs, Connecticut, USA.

Abstract

This article describes the results of sequencing and analysis of the entire genome of the SARS-CoV-2 virus sampled in Kazakhstan in 2021. The whole-genome sequence of the strain was 29,751 bp. According to the results of phylogenetic analysis (according to the Pangolin COVID-19 database), the SARS-CoV-2/human/KAZ/B1.1/2021 strain studied here was assigned to variant B.1.1.

Grants and funding

AP09058338 "STUDY OF ANTI-VIRAL ACTIVITY OF DRUGS AGAINST SARS-COV-2 VIRUS IN VITRO."/Ministry of Education and Science of the Republic of Kazakhstan (Ministry of Education and Science, Republic of Kazakhstan)